1、Fueling the APAC Medtech Innovation Engine:An Ecosystem InvestmentAPACMed&L.E.K.ConsultingSeptember 2024Contents1.Foreword.32.Approach.43.Executive summary.54.APAC early-stage innovation is at risk.114.1.Funding under threat:declines in medtech investment.114.2.Direct cost challenge:rising costs and

2、 operational uncertainties.124.3.The ecosystem should step in to support innovation.145.Building a more supportive ecosystem.165.1.Regulatory authorities:acceleration through approval,market access and payment.175.2.Governments:funding and incentives fueling the medtech innovation engine.275.3.Unive

3、rsities and research institutions:nurturing the seeds of innovation.315.4.Large medtech firms:catalysts of innovation in a challenging market.345.5.Investors(family offices):fuel for the engine.405.6.Industry associations and accelerators:a unified voice for innovation.415.7.Startup companies:the ba

4、sis of ecosystems.426.Recommendations for implementations.447.Acknowledgments.488.References.502 APACMed|L.E.K.ConsultingTOPFueling the APAC Medtech Innovation Engine:An Ecosystem Investment1.ForewordEarly-stage medtech innovation is a lifeblood of healthcare systems around the world.Many of todays

5、leading medtech conglomerates began as small,visionary startups.These companies,once fledgling enterprises,have grown into industry titans,driving forward the frontiers of medical science and technology.However,the journey from a small business to a global giant is fraught with challenges,particular

6、ly within the healthcare sector which is characterized by a high-risk,high-reward profile.The medtech industry stands at a pivotal juncture.The inherent risks associated with healthcare innovation regulatory hurdles,elongated R&D timelines,fragmented commercial opportunities,a varied reimbursement e